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We have assayed a variety of 7tm chemokine receptors (CCR-2b, CCR-3, CCR-4, CCR-5, CXCR-1, CXCR-4) and two orphan
7tm receptors (V28 and EBI.1) for their ability to allow infection of CD4-negative feline kidney CCC cells by the HIV-2 strains
ROD/A and ROD/B. We found that ROD/B was able to use CXCR-4 transiently expressed in CCC cells, and infection by
ROD/A was enhanced 15-fold in the presence of sCD4. Feline CCC cells also became permissive to ROD/B and ROD/A
entry when transiently transfected with the chemokine receptor CCR-3 or the orphan 7tm receptor V28, when cultured in
the presence of sCD4. Entry of ROD/A into CCC cells expressing CCR-3 could be blocked by 800 ng/ml eotaxin, the natural
ligand for CCR-3. q 1997 Academic Press
INTRODUCTION Several laboratories have shown that some HIV iso-
lates can infect lymphoid (Clapham et al., 1992; McKnight
The primary receptor for the human and simian immu-
et al., 1994) and nonlymphoid cells (Clapham et al., 1992;
nodeficiency viruses (HIV-1, HIV-2, and SIV) is the CD4
Harouse et al., 1989; Talbot et al., 1995; Tateno et al.,
molecule (Maddon et al., 1986). The restriction to HIV-1
1989) in the absence of CD4, although infection in most
entry into certain CD4-positive cells is due to the absence
of these examples is extremely inefficient. We reported
of a specific cofactor essential for fusion. Recently two
an HIV-2 strain, ROD/B (derived from the prototype HIV-
members of the seven transmembrane (7tm), G-protein
2 strain ROD/A), that can directly induce cell–cell fusion
coupled chemokine receptor family of proteins, CXCR-4
and efficiently infect certain CD4-negative human cell
(also termed Fusin or Lestr) and CCR-5, have been
lines (Clapham et al., 1992). The implications of this are
shown to function as coreceptors, together with CD4, for
that ROD/B simply bypasses CD4 and interacts directly
T-cell line and macrophage tropic HIV-1 isolates, respec-
with an alternative receptor. To directly test this hypothe-
tively (Alkhatib et al., 1996; Deng et al., 1996; Dragic et
sis we have expressed a variety of human 7tm receptors
al., 1996; Feng et al., 1996). Other members of this family,
in feline kidney CCC cells.
CCR-3 and CCR-2b, have also been shown to act as
coreceptors for a limited number of primary HIV-1 iso-
MATERIALS AND METHODSlates (Berson et al., 1996; Choe et al., 1996; Doranz et
al., 1996). It has been suggested that the HIV envelope Cell lines and viruses
glycoprotein may associate with or interact directly with
The feline kidney cell line: CCC (Crandell et al., 1973)these 7tm proteins subsequent to CD4 binding (Berson
was maintained as a monolayer in DMEM media (Gibco)et al., 1996; Deng et al., 1996; Dragic et al., 1996; Feng
supplemented with 5% (v/v) FCS, 60 mg/ml penicillin, andet al., 1996). Recently the coprecipitation of a gp120-CD4-
100 mg/ml streptomycin. The HIV-2 strain ROD/B (Clap-CXCR4 complex with anti-CD4 or gp120 antibodies has
ham et al., 1992) was derived from C8166 cells chroni-been demonstrated (Lapham et al., 1996), providing com-
cally infected with ROD/A (Clavel et al., 1986).pelling evidence for a direct association between HIV
envelope, CD4, and coreceptor during the infection of
Construction of plasmidscells. Competitive inhibition of the chemokine MIP1b
binding to its receptor CCR-5 by gp120 has also recently The 7tm chemokine receptors (CCR-2b, CCR-3, CCR-
been demonstrated (Trkola et al., 1996; Wu et al., 1996). 4, CCR-5, CXCR-1, CXCR-4) and two orphan 7tm recep-
tors (V28 and EBI.1) were subcloned into the vector
pCDNA3.1 (Invitrogen) for transfection and expression in1 To whom correspondence and reprint requests should be ad-
dressed. Fax: /44 171 352 3299. E-mail: simon@icr.ac.uk. CCC cells.
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Transfection of CCC cells
CCC cells (21 106) were seeded in an 8.5-cm diameter
dish and 24 hr later transfected using Lipofectamine (ac-
cording to manufacturers instructions - Gibco) and 6 mg
of plasmid DNA encoding the indicated 7tm receptor
(cloned into pCDNA3.1; Invitrogen).
Infection of CCC cells
Twenty-four hours posttransfection, cells were split
into 48- or 24-well trays and infected with virus 24 hr
later. Infections were performed in triplicate using 100
or 200 ml of serially diluted virus, in the presence or
FIG. 1. Cell-free infection of feline kidney CCC cells expressing sev-absence of sCD4 (2 mg/ml). Virus was allowed to adsorb
eral 7tm receptors by ROD/B or ACR23 (molecular clone of ROD/A).to cells for 3 hr at 377 before unbound virus was removed
Cells were immunostained for the presence of HIV-2 envelope glyco-
and replaced with appropriate media. Infected cells were proteins 3 days postinfection. Infected cells appear black in the photo-
immunostained after a further 3 days incubation. graphs.
Immunostaining HIV-2 infected cells
ham et al., 1992). Productive cell-free infection by ROD/
B, and to a lesser extent ROD/A, was observed in CCCThree days postinfection, the media was removed and
the cells were washed twice in PBS, before fixing with cells transfected with CXCR-4 (Figs. 1 and 2a). Infection
of CCC cells expressing CXCR-4 with ROD/B could bea 50/50 mixture of methanol/acetone at 0407 for 2 min.
After removal of the methanol/acetone the cells were blocked with 4 mg/ml of the Mab 12G5 (reactive against
CXCR-4 (Endres et al., 1996; McKnight et al., 1997)) butwashed once with PBS followed by PBS containing 1%
(v/v) FCS. The primary antibody (44.2g, a MAb against not with up to 20 mg/ml of an anti-CD4 Mab (Q4120) (Fig.
3a). The specificity of this blocking implies that ROD/BROD/B envelope (McKnight et al., 1996); 100 ml/well, di-
luted 1:50 in PBS-1% FCS) was added to the fixed cells, interacts directly with CXCR-4 as a primary receptor to
gain entry into CD4-negative cells.allowed to bind for 1 hr at room temperature, and then
the monolayer was washed two times in PBS–1% FCS. We consistently observed low levels (⁄102 ffu/ml) of
infection of untransfected CCC cells, by both ROD/B andGoat anti-rat IgG-b-galactosidase conjugate (Sera-labs)
at a dilution of 1:400 (in PBS-1% FCS) was added for 1 ROD/A, which could be neutralized by 10 mg/ml of a
neutralizing monoclonal antibody (Mab), 28.8e (McKnighthr at room temperature and then the monolayer was
washed three times in serum-free PBS. Two hundred et al., 1996) (data not shown). These data suggest that
both ROD/B and ROD/A are able to utilize (albeit ineffi-microliters of 5-bromo-4-chloro-3-b-D-galactopyranoside
(X-gal) substrate (0.5 mg/ml) in PBS containing 3 mM ciently) an endogenous feline 7tm receptor to gain entry
(possibly feline CXCR-4, which is expressed on thesepotassium ferricyanide, 3 mM potassium ferrocyanide,
and 1 mM magnesium chloride was added to each well. cells—data not shown).
Infected cells stained blue within 1 to 2 hr of the addition
HIV-2 ROD infection of CCC cells expressing CCR-3of substrate.
or the orphan 7tm receptor V28 is enhanced in the
presence of sCD4RESULTS
It has been shown previously that pretreatment of cer-The HIV-2 strains ROD/B and ROD/A efficiently use
tain CD4-dependent strains of HIV-2 (such as ROD/A)CXCR-4 as a primary receptor for entry of CD4-
with sCD4 can trigger fusion and entry into CD4-negativenegative CCC cells
cells (Clapham et al., 1992). Infection with ROD/B in the
presence of 2 mg/ml of sCD4 (MRC AIDS reagent project)The CD4-negative feline CCC cell line is normally re-
strictive for HIV entry but is permissive for replication of had no effect on the entry of CXCR-4 expressing cells
but increased the titer of ROD/B by 10-fold on CCC cellsthe virus (McKnight et al., 1994). Cells were transiently
transfected with plasmids expressing several known expressing CCR-3 and by 3-fold on CCC cells expressing
the putative (orphan) 7tm receptor V28. The parentalchemokine receptors (CCR-2b, CCR-3, CCR-4, CCR-5,
CXCR-1, CXCR-4) and two orphan 7tm receptors (V28 strain ROD/A was found to efficiently enter CCC cells
expressing CXCR-4 when induced with sCD4. Similarly,and EBI.1 (Raport et al., 1995)) and challenged with ROD/
B or a molecular clone of ROD/A (ACR23) 48 hr later. low levels (significantly above background) of infection
of CCC cells expressing either CCR-3 or V28 could beInfected cells were immunostained for the production of
HIV-2 envelope glycoproteins 3 days postinfection (Clap- induced with sCD4 (Fig. 2).
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Infection of CCC cells expressing CCR-3 is blocked
by eotaxin
The natural ligand for CCR-3 is the chemoattractant
eotaxin (Ponath et al., 1996). The data in Fig. 3b show
that entry of ROD/A into CCC cells expressing CCR-3 is
blocked by the addition of 400–800 ng/ml of eotaxin, but
that eotaxin does not block entry of ROD/A into CCC cells
expressing CXCR-4. These data provide strong evidence
that ROD/A can specifically use CCR-3 to enter cells.
The putative 7tm protein V28, has sequence similarity
to the genes encoding human chemokine receptors for
MCP-1 and MIP-1a/RANTES (Raport et al., 1995), al-
though the natural ligand for V28 has yet to be estab-
lished. V28 is most highly expressed in neural and
FIG. 3. (a) Relative infection of CCC cells expressing CXCR-4 by
ROD/B in the presence of increasing concentrations of the anti-CXCR-
4 Mab 12G5 (Endres et al., 1996) or the anti-CD4 Mab Q4120 (MRC
AIDS reagent project). (b) Relative infection of CCC cells expressing
CCR-3 or CXCR-4 by ROD/A in the presence of increasing concentra-
tions of the CCR-3 ligand, eotaxin (Peprotech Ltd.). Cells were incubated
with eotaxin for 30 min prior to and during the infection (2 hr) with the
virus. Infection was performed in the presence of sCD4 (2 mg/ml).
lymphoid tissues (Raport et al., 1995) but has not been
shown to be involved in the CD4-dependent entry of cells
by HIV-1 (L. Picard and G. Simmons, unpublished). The
data in Fig. 2b indicate ROD is able to use this 7tm
molecule, albeit inefficiently, in the presence of sCD4.
We have found no evidence for ROD/B or ROD/A infection
FIG. 2. Cell-free infection of CCC cells expressing (a) CXCR-4 or (b) of CCC cells expressing CCR-2b, CCR-4, CCR-5, CXCR-
CCR-3, CCR-5, or V28, by ROD/B or ACR23 (molecular clone of ROD/
1, or the orphan receptor EBI.1 (data not shown).A). Where indicated cells were infected with virus in the presence
sCD4 (2 mg/ml; MRC AIDS reagent project). Data represent the average
number of foci forming units per milliliter of input virus (ffu/ml) and DISCUSSION
standard deviations from infections performed in triplicate. The low
background level of infection of mock-transfected CCC cells suggests Recent data has provided strong evidence for the di-
that ROD/B and ACR23 are able to utilize (albeit inefficiently) an endoge- rect interaction of the HIV envelope glycoprotein with
nous feline 7tm receptor to gain entry (possibly feline CXCR-4, which
both CXCR-4 and CD4 (Lapham et al., 1996; Trkola et al.,is expressed on these cells—data not shown). CCC cells transfected
1996; Wu et al., 1996). The secondary interaction withwith four other 7tm receptors (CCR-2b, CCR-4, CXCR-1, and EBI.1) were
not infected by ROD/B or ACR23 (data not shown). one or more 7tm protein coreceptors may be dependent
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Berson, J. F., Long, D., Doranz, B. J., Rucker, J., Jirik, F. R., and Doms,on conformational changes induced by interaction with
R. W. (1996). A seven-transmembrane domain receptor involved inCD4 (Deng et al., 1996; Doranz et al., 1996). The data
fusion and entry of T-cell-tropic human immunodeficiency virus type
presented here showing the efficient CD4-independent 1 strains. J. Virol. 70(9), 6288–6295.
entry of cells via the use of the chemokine receptor Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P. D., Wu,
CXCR-4 confirm and extend the observations of Endres L., Mackay, C. R., LaRosa, G., Newman, W., Gerard, N., Gerard, C.,
and Sodroski, J. (1996). The beta-chemokine receptors CCR3 andet al. (1996), and provide further evidence for a direct
CCR5 facilitate infection by primary HIV-1 isolates. Cell 85(7), 1135–interaction between these two molecules. The mutations
1148.in the ROD/B envelope (SU and TM) which are responsi-
Clapham, P. R., McKnight, A´., and Weiss, R. A. (1992). Human immuno-
ble for its CD4-independent phenotype (Reeves and deficiency virus type 2 infection and fusion of CD4-negative cell lines:
Schulz, 1996) have recently been mapped. One of the four induction and enhancement by soluble CD4. J. Virol. 66(6), 3531–
3537.essential amino acid changes from the ROD/A genotype
Clavel, F., Guetard, D., Brun-Vezinet, F., Charmaret, S., Rey, M. A., San-resides in the TM protein, two flank the V4 loop and the
tos-Ferreira, M. O., Laurent, A. G., Dauget, C., Katlama, C., Rouzioux,fourth change, which alone enhances a minimal CD4-
C., Klatzmann, D., Champalimaud, J. L., and Montagnier, L. (1986).
independent phenotype, is in the V3 loop (Reeves and Isolation of a new human retrovirus from West African patients with
Schulz, 1996). The V3 loop is not involved in the interac- AIDS. Science 233, 343–346.
Cohen, J. (1995). Differences in HIV strains may underlie disease pat-tion of the envelope with CD4 but has been implicated
terns [news]. Science 270(5233), 30–31.in coreceptor utilization (Choe et al., 1996). It has been
Crandell, R. A., Fabricant, C. G., and Nelson-Rees, W. A. (1973). Devel-proposed that HIV requires an initial interaction with CD4
opment, characterisationand virus susceptibility of a feline (Felis ca-to induce conformational changes within the envelope tus) renal cell line (CRFK). In Vitro 9, 176–185.
which are essential for the subsequent fusion event in- Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Di
volving 7tm membrane proteins (Deng et al., 1996; Dor- Marzio, P., Marmon, S., Sutton, R. E., Hill, C. M., Davis, C. B., Peiper,
S. C., Schall, T. J., Littman, D. R., and Landau, N. R. (1996). Identifica-anz et al., 1996). The mutations in the ROD/B envelope
tion of a major co-receptor for primary isolates of HIV-1 [see com-could remove the necessity for CD4 priming by lowering
ments]. Nature 381(6584), 661–666.the activation threshold required for triggering conforma-
Doranz, B. J., Rucker, J., Yi, Y., Smyth, R. J., Samson, M., Peiper, S. C.,
tional changes in the envelope glycoproteins that lead Parmentier, M., Collman, R. G., and Doms, R. W. (1996). A dual-tropic
to fusion (Reeves and Schulz, 1996) or by increasing the primary HIV-1 isolate that uses fusin and the beta-chemokine recep-
affinity of the interaction of the envelope SU (probably via tors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85(7), 1149–
1158.the V3 loop) with CXCR-4. Interestingly, ROD/B required
Dragic, T., Litwin, V., Allaway, G. P., Martin, S. R., Huang, Y., Nagashima,activation with sCD4 for entry into cells expressing two
K. A., Cayanan, C., Maddon, P. J., Koup, R. A., Moore, J. P., and Paxton,other 7tm receptors (CCR-3 and V28), suggesting that
W. A. (1996). HIV-1 entry into CD4/ cells is mediated by the chemo-
distinct regions of the envelope need to be exposed be- kine receptor CC-CKR-5 [see comments]. Nature 381(6584), 667–
fore interaction with these molecules can occur. 673.
Endres, M. J., Clapham, P. R., Marsh, M., Ahuja, M., Davis-Turner, J.,It still remains to be shown whether the use of 7tm
McKnight, A´., Thomas, J. F., Stoenbenay-Haggarty, B. S., Choe, S.,receptors as primary receptors in the absence of CD4
Vance, P. J., Wells, T., Power, C. A., Sutterwala, S. S., Landau, N. R.,has relevance for pathogenesis of HIV in vivo. However,
and Hoxie, J. A. (1996). CD4-independent infection by HIV-2 is medi-
there is evidence for the productive infection of cells that ated by CXCR-4. Cell 87, 745–756.
are apparently CD4-negative in tissues from HIV-infected Feng, Y., Broder, C. C., Kennedy, P. E., and Berger, E. A. (1996). HIV-1
humans (Cohen, 1995; Housset et al., 1993; Livingstone entry cofactor: functional cDNA cloning of a seven-transmembrane,
G protein-coupled receptor [see comments]. Science 272(5263),et al., 1996; Wiley et al., 1986). We have shown here that
872–877.HIV-2 can utilize divergent members of the family of 7tm
Harouse, J. M., Kunsch, c., Hartle, H. T., Laughlin, M. A., Hoxie, J. A.,receptors (with CXCR-4 being used efficiently in the ab-
Wigdahl, B., and Gonzalez-Scarano, F. (1989). CD4-independent in-
sence of CD4). The implications of these data are that fection of human neural cells by HIV-1. J. Virol. 63(2527).
HIV could evolve in vivo to bypass CD4 for infection of Housset, C., Lamas, E., Courgnaud, V., Boucher, O., Girard, P. M., Mar-
the immune, hematopoietic, and/or nervous systems. che, C., and Brechot, C. (1993). Presence of HIV-1 in human paren-
chymal and non-parenchymal liver cells in vivo. J. Hepatol. 19(2),
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